Charles Bennett to Models, Economic
This is a "connection" page, showing publications Charles Bennett has written about Models, Economic.
Connection Strength
0.570
-
Upping recruitment in clinical trials: are the costs worth it? Onkologie. 2009 Jul; 32(7):378-9.
Score: 0.316
-
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
Score: 0.127
-
Pharmacoeconomics of amifostine in ovarian cancer. Semin Oncol. 1999 Apr; 26(2 Suppl 7):102-7.
Score: 0.039
-
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
Score: 0.038
-
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? Clin Perform Qual Health Care. 1995 Jul-Sep; 3(3):156-64.
Score: 0.030
-
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening. J Clin Oncol. 2009 Nov 10; 27(32):5370-5.
Score: 0.020